Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for ...
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-oriented, multispecialty ophthalmology CME ...
SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback